Kythera Biopharmaceuticals Inc. 's ( KYTH ) MACD indicator has moved into bearish territory with a reading of -0.1667. The Zacks Rank #4 ("Sell") stock decreased more than 2.85% to $22.47 in morning trade.

LOS ANGELES, May 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of America Merrill Lynch 2013 Healthcare ...

LOS ANGELES, May 13, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2013, and provided an update on recent accomplishments.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.

(RTTNews.com) - KYTHERA Biopharmaceuticals, Inc. ( KYTH ) will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas.

based Merrimack Pharmaceuticals Inc. raised $100 million and Cambridge-based Verastem Inc., raised $55 million; New York-based Intercept Pharmaceuticals Inc. raised $75 million; and Calabasas, Calif.

... May AMC Q1 2013 INFORMATION SERVICES GROUP INC 0.01 3 0.03 13 May AMC Q1 2013 International Meal Company Holding 0.06 2 N/A 13 May AMC Q1 2013 InfuSystem Holdings Inc 0.01 1 N/A 13 May Q1 2013 Kythera Biopharmaceuticals -0.97 3 ...